Tavaborole Patent Expiration
Tavaborole is Used for treating onychomycosis (fungal infection of the toenail). It was first introduced by Anacor Pharmaceuticals Inc
Tavaborole Patents
Given below is the list of patents protecting Tavaborole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kerydin |
US7582621 (Pediatric) | Boron-containing small molecules | Nov 26, 2027 | Anacor Pharms Inc |
| Kerydin | US7582621 | Boron-containing small molecules | May 26, 2027 | Anacor Pharms Inc |
| Kerydin | US7767657 | Boron-containing small molecules | May 22, 2027 | Anacor Pharms Inc |
| Kerydin |
US9549938 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566289 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566290 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9572823 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9549938 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566289 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566290 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9572823 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
Tavaborole's Family Patents
Explore Our Curated Drug Screens
Tavaborole Generic API Manufacturers
Several generic applications have been filed for Tavaborole. The first generic version for Tavaborole was by Encube Ethicals Private Ltd and was approved on Oct 13, 2020. And the latest generic version is by Zydus Lifesciences Ltd and was approved on Apr 10, 2023.
Given below is the list of companies who have filed for Tavaborole generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Oct 21, 2020 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Nov 25, 2020 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 3, 2021 |
4. CIPLA
Cipla Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 9, 2021 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
5. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%
(reference standard) | solution | Prescription | TOPICAL | AB | Oct 13, 2020 |
Manufacturing Plant Locations New
Encube's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
6. LUPIN LTD
Lupin Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 8, 2021 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
7. PADAGIS US
Padagis Us Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Oct 13, 2020 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
8. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | May 7, 2021 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||
9. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Apr 10, 2023 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||